Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
PLSE
#2243
Pulse Biosciences, Inc Common Stock (DE)
20.120
0
USD
+6.34%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+6.34%
Aylık Değişim
-6.72%
6 aylık değişim
+10.85%
Yıllık Değişim
+10.85%
Önceki Kapanış
18.920
0
Open
20.120
0
Bid
Ask
Low
20.120
0
High
20.120
0
Hacim
57
Piyasalar
ABD Borsası
Sağlık Hizmetleri
PLSE
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.09 M
29.8 M
37.59 M
55.23 M
67.27 M
67.99 M
—
Valuation ratios
Enterprise value
609.97 M
424.01 M
52.28 M
573.36 M
1.05 B
852.76 M
3.83 B
Price to earnings ratio
—
—
-1.6
-12.54
-18.97
-12.71
-58.35
Price to sales ratio
—
—
133.32
—
—
2 643.82
—
Price to cash flow ratio
—
—
-1.99
-16.02
-27.98
-17.1
-87.29
Price to book ratio
—
—
-41.51
11.93
8.85
11.47
19.35
Enterprise value to EBITDA ratio
-12.36
-12.18
-1.16
-37.07
-19.12
-11.14
-68.7
Profitability ratios
Return on assets %
-1.21
-1.17
-0.75
-0.71
-0.4
-0.77
-0.65
Return on equity %
-2.18
-1.78
26.03
-0.95
-0.47
-0.9
-0.75
Return on invested capital %
-761.9
-1 240.68
-1 276.4
-1 075.01
-1 538.65
-2 275.12
—
Gross margin %
—
-38.79
-1 606.29
—
—
-54
—
Operating margin %
—
-4 443.86
-8 293.86
—
—
-21.98 K
—
EBITDA margin %
—
-2 390.27
-5 191.86
—
—
-21.87 K
—
Net margin %
—
-4 489.42
-8 357.86
—
—
-20.79 K
—
Liquidity ratios
Quick ratio
—
3.62
10.39
—
—
10.51
48.14
Current ratio
2.95
4.3
10.39
6.76
11.88
10.53
48.17
Inventory turnover
—
0.1
2.91
—
—
—
—
Asset turnover
0
0.03
0.01
0
0
0
0
Solvency ratios
Debt to assets ratio
—
0.21
0.13
0.15
—
—
—
Debt to equity ratio
—
0.32
-4.47
0.21
—
—
—
Long term debt to total assets ratio
—
0.01
0
0
—
—
—
Long term debt to total equity ratio
—
0.01
0
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.39
-0.69
-0.62
-0.8
-0.8
EBIT per share
—
—
-1.71
-0.91
-0.96
-1.14
-1.14
EBITDA per share
—
—
-1.07
-0.32
-0.94
-1.14
-0.79
Total debt per share
—
—
0.3
0.19
—
—
—
Cash per share
—
—
1.8
0.92
2.02
1.2
5.97
Net current asset value per share
—
—
1.83
0.94
2.05
1.24
6.09
Tangible book value per share
—
—
0.01
0.99
2.03
1.27
6.15
Working capital per share
—
—
1.66
0.8
1.87
1.12
5.58
Book value per share
—
—
-0.07
0.92
1.97
1.2
5.89
Haberler
Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study
Pulse Biosciences, Liane Teplitsky’yi COO olarak atadı
Pulse Biosciences atriyal fibrilasyon için kritik çalışma başlattı
PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data
Pulse Biosciences Oppenheimer Konferansı: AF Ablasyon Sonuçları Umut Verici
Pulse Biosciences odağını kardiyak kateter programına kaydırıyor
Pulse Biosciences shifts focus to cardiac catheter program
Pulse Biosciences tiroid kanseri çalışmasına ilk hastaları kaydetti
Pulse Biosciences enrolls first patients in thyroid cancer study
Pulse Biosciences ticari direktörü derhal istifa etti
Pulse Biosciences chief commercial officer resigns effective immediately
Pulse Biosciences CCO Danahy 118 bin dolarlık hisse sattı